Community Health Systems Inc (CYH)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Community Health Systems Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 6 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 2.90 $ — 21% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/04/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AAQS
1/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% -4.2%
- Exp. sales growth 3Y > 5% -3.8%
- EBIT growth 10Y > 5% –
- Exp. EBIT growth 3Y > 5% -3.8%
- Net debt < 4x EBIT –
- EBIT positive, 10Y straight 7
- Max. EBIT decline < 50% 100.0%
- Return on equity > 15% –
- ROCE > 15% -90.2%
- Expected return > 10% 45.6%
View all AAQS quality stocks · Read the methodology at AlleAktien
Source: fundamental data
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
4 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 0.7% failed
- More than 10% revenue growth is expected for the coming year 1.6% failed
- Share count grows by less than 3% a year 1.3% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 0.5% failed
- Gross margin at 40% or higher and without meaningful erosion 8.7% failed
- Goodwill from acquisitions does not grow faster than revenue 25.1% passed
- Net debt below twice EBITDA 5.6 x EBITDA failed
- Operating cash flow covers the profits of the last three years 1,373 m passed
- Return on capital at 15% or higher, or up versus two years ago -90.2% failed
- Insiders hold at least 10% or are net buyers 15.2% passed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 9.7% above the current price.
- Consensus
- Hold
- Analyst Ratings
- 9
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -1.17 | -1.23 – -1.11 | 11,449 | -198.0% | 5 |
| 12/31/2027 | -0.41 | -0.81 – 0.36 | 11,560 | 64.8% | 7 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- -0.38 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.53 | -248.90 | 3,265 | 2.60 | -2.10 | 216 | 107 |
| 2025: Q1 | -0.10 | – | 3,159 | 0.60 | -0.40 | 120 | 35 |
| 2025: Q2 | 2.09 | – | 3,133 | -0.20 | 9.00 | 88 | -3 |
| 2025: Q3 | 0.96 | – | 3,087 | -0.10 | 4.20 | 69 | 4 |
| 2025: Q4 | 0.81 | – | 3,106 | -4.90 | 3.50 | 266 | 172 |
| 2026: Q1 | -0.43 | – | 2,965 | -6.10 | -2.00 | -297 | -373 |
| 2026: Q2 | 0.51 | -75.60 | 2,825 | -9.80 | 2.50 | 88 | 12 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 18,438 | -860 | -1,721 | -15.54 | 1,137 | 1,615 | 21,944 |
| 2017 | 15,353 | -1,878 | -2,459 | -22.00 | 773 | -767 | 17,450 |
| 2018 | 14,155 | 208 | -788 | -6.99 | 274 | -1,535 | 15,859 |
| 2019 | 13,210 | 650 | -590 | -5.19 | 385 | -2,218 | 15,609 |
| 2020 | 11,789 | 1,126 | 511 | 4.38 | 2,178 | -1,625 | 16,006 |
| 2021 | 12,368 | 1,402 | 230 | 1.76 | -131 | -1,372 | 15,217 |
| 2022 | 12,211 | 821 | 46 | 0.35 | 300 | -1,367 | 14,669 |
| 2023 | 12,490 | 957 | -133 | -1.02 | 210 | -1,392 | 14,455 |
| 2024 | 12,634 | 542 | -516 | -3.91 | 480 | -1,914 | 14,054 |
| 2025 | 12,485 | -9,915 | 509 | 3.77 | 543 | -1,394 | 13,204 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Community Health Systems, Inc. besitzt, least und betreibt allgemeine Akutkrankenhäuser in den USA.
| Employees | 44,000 |
|---|---|
| Headquarters | Franklin, TN |
| Address | 4000 Meridian Boulevard, 37067 Franklin, United States |
| Phone | 615 465 7000 |
| Website | chs.net |
| IPO Date | 7. Mar 1991 |
| ISIN | US2036681086 |
| Stock Split | 121:100 on 04/22/2016 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Kevin J. Hammons CPA | President, CEO & Director | 1966 |
| Jason K. Johnson | CFO & Executive VP | 1975 |
| Kevin A. Stockton | Executive Vice President of Operations & Development | 1971 |
| Mark B. Medley | President of Region 3 Operations | 1966 |
| Chad A. Campbell | President of Region 2 Operations | 1970 |
| Justin D. Pitt | President, Chief Legal Counsel and Administrative Officer & Assistant Secretary | 1976 |
| Phillip A. Posey | Senior VP & Chief Accounting Officer | 1985 |
| Shelly K. Schussele | Senior Director of Investor Relations | – |
| Beth Witte | Senior VP and Chief Compliance & Privacy Officer | – |
| Tomi J. Galin | Executive Vice President of Corporate Communications, Marketing & Public Affairs | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.